Crohn?s Disease Therapeutics Market

Prevalence of Crohn?s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure to sunlight, changes in diet, smoking, and genetic characteristics. According to the Centers for Disease Control and Prevention (CDC), over 1 million Americans suffer from inflammatory bowel disease every year.
Crohn?s Disease Therapeutics Market contains market size and forecasts of Crohn?s Disease Therapeutics in Global, including the following market information:
Global Crohn?s Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Crohn?s Disease Therapeutics market was valued at 3416.4 million in 2021 and is projected to reach US$ 3750 million by 2028, at a CAGR of 1.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Surgical Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Crohn?s Disease Therapeutics include Johnson and Johnson Services Inc., Pfizer Inc., Allergan, AbbVie Inc., Takeda Pharmaceutical Company Limited, Celgene Corporation, Perrigo Company PLC, Ferring B.V. and Salix Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Crohn?s Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Crohn?s Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Crohn?s Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
Non-Surgical
Surgical
Global Crohn?s Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Crohn?s Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Global Crohn?s Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Crohn?s Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Crohn?s Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Crohn?s Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.